<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29408" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Sports Participation Evaluation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Farzam</surname>
            <given-names>Khashayar</given-names>
          </name>
          <aff>McMaster University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Daley</surname>
            <given-names>Sharon F.</given-names>
          </name>
          <aff>Cape Cod Hospital, Hyannis, MA</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Akhondi</surname>
            <given-names>Hossein</given-names>
          </name>
          <aff>University of Nevada</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Khashayar Farzam declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sharon Daley declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hossein Akhondi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29408.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The goal of evaluating amateur and professional athletes before sports participation is to ensure their health before&#x000a0;competing in a particular sport. Many sports associations and leagues require a health examination and documentation of clinical findings to&#x000a0;maximize safe participation by children, adolescents, and young adults and to identify medical problems with risks of life-threatening complications that limit or exclude them from play. Evaluation includes assessment of personal and family medical history, medications and supplements, review of systems, focused physical examination, and, occasionally, diagnostic testing. This activity reviews the fundamental components of the sports participation evaluation by the interprofessional team and how these evaluations can be optimized to ensure that&#x000a0;athletes&#x000a0;can engage in their chosen sport&#x000a0;and limit serious risks and injuries.&#x000a0;</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the essential personal and family medical history items to address in the pre-participation evaluation.</p></list-item><list-item><p>Summarize the physical examination findings in a prospective athlete limiting or prohibiting sports participation.</p></list-item><list-item><p>Review the indications for diagnostic testing and specialty referrals for prospective athletes.</p></list-item><list-item><p>Develop a plan for the interprofessional team to screen and educate patients on safe sports participation.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29408&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29408">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29408.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Evaluating amateur and professional athletes before sports participation ensures their health before&#x000a0;competing. Many sports associations and leagues require a health examination and documentation of clinical findings to&#x000a0;maximize safe participation and identify medical problems with risks of life-threatening complications that limit or exclude play. Many professional groups make&#x000a0;specific recommendations, including the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Sports Medicine, the American Society for Sports Medicine, the American Orthopedic Society for Sports Medicine, the American Osteopathic Society for Sports Medicine, the American Heart Association, and the European Society of Cardiology.<xref ref-type="bibr" rid="article-29408.r1">[1]</xref>&#x000a0;</p>
        <p>The assessment is not intended to replace comprehensive health maintenance or well-child visits but&#x000a0;rather&#x000a0;to identify medical problems that might result in severe complications during play, conditions that require a treatment plan or rehabilitation before participation, and other concerns that unnecessarily restrict athletes from joining a sport. The&#x000a0;necessary components are the personal and family medical history, a thorough review of systems, a targeted physical examination, diagnostic studies or referrals when indicated, and a recommendation for full, limited, or no participation.<xref ref-type="bibr" rid="article-29408.r2">[2]</xref><xref ref-type="bibr" rid="article-29408.r3">[3]</xref>&#x000a0;A standardized form to document these findings, endorsed by most professional organizations, can be found at the American Academy of Pediatrics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.AAP.org">website</ext-link>.<xref ref-type="bibr" rid="article-29408.r2">[2]</xref></p>
        <p>Practical considerations include the timing, frequency, and setting of the examination.&#x000a0;The ideal time is four to six weeks before the sports season begins. Usually,&#x000a0;assessments are required&#x000a0;for each new level of school, such as middle school, high school, and university, with yearly updates in between. When conducted in an office setting, the advantages are patient privacy and continuity of care with primary care clinicians. The alternative is the station approach with multiple examiners. This can be time efficient, sports-oriented, less costly, and effective at identifying abnormalities but lacks privacy and continuity of care.&#x000a0;</p>
        <p>The following details the essential elements of the pre-participation evaluation and recommendations regarding specific abnormal findings.&#x000a0;</p>
      </sec>
      <sec id="article-29408.s3" sec-type="Function">
        <title>Function</title>
        <p>The primary purpose of the sports pre-participation evaluation is to&#x000a0;screen for underlying medical conditions and to ensure&#x000a0;the athlete is in optimal health for the chosen sport. The athlete's personal and family medical history identifies most conditions that restrict participation or require further evaluation. The following&#x000a0;are critical components of the history, review of systems, and physical examination.&#x000a0;</p>
        <p>
<bold>Personal Medical History&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiovascular conditions with increased risk of sudden death, including hypertension,&#x000a0;heart murmur, Kawasaki disease, myocarditis, unexplained syncope, and unexplained seizures<xref ref-type="bibr" rid="article-29408.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Previous injuries, including musculoskeletal trauma and concussions, primarily if they resulted in being excluded from play</p>
          </list-item>
          <list-item>
            <p>Recent significant weight gain or loss and athlete's perception of current weight</p>
          </list-item>
          <list-item>
            <p>Prior heat-related illness</p>
          </list-item>
          <list-item>
            <p>Recent serious infections, including COVID-19</p>
          </list-item>
          <list-item>
            <p>Loss of function of a paired organ, such as the eye, testis, or kidney</p>
          </list-item>
          <list-item>
            <p>Menstrual history in females</p>
          </list-item>
        </list>
        <p>
<bold>Family Medical History</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Death&#x000a0;or disability from cardiac causes, including unexplained sudden death in a close family member younger than 50 years of age and unexplained drowning&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Heritable cardiomyopathies or arrhythmia syndromes, such as hypertrophic cardiomyopathy and prolonged QT, presence of a pacemaker or implanted defibrillator, and Marfan syndrome&#x000a0;<xref ref-type="bibr" rid="article-29408.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Undiagnosed syncope</p>
          </list-item>
          <list-item>
            <p>Muscular dystrophies</p>
          </list-item>
        </list>
        <p>
<bold>Current Medications, Supplements, and Substance Use</bold>
</p>
        <p>Athletes commonly use health and nutritional supplements.&#x000a0;Some supplements contain ingredients that pose a health risk and are banned from use by the World Anti-Doping Agency (WADA). Also, certain supplements, such as specific stimulants, may be legal but pose long-term cumulative health risks when used in high doses. Performance-enhancing drugs (PEDs) and recreational&#x000a0;substances are cause for concern in athletes. PEDs are highly sport-specific, with the most commonly used ones categorized as anabolic agents and stimulants. Anabolic drugs are classified&#x000a0;as anabolic-androgenic steroids (AAS) and peptide hormones. Prescribed&#x000a0;medications should be&#x000a0;reviewed due to the potential for causing athletes to fail a drug test or&#x000a0;affecting their performance.<xref ref-type="bibr" rid="article-29408.r6">[6]</xref>&#x000a0;</p>
        <p>
<bold>Immunizations</bold>
</p>
        <p>Sports participation is a mechanism for spreading vaccine-preventable communicable infections. Athletes are at risk due to shared travel spaces, food, water bottles, and equipment, as well as potential close exposure to body fluids and travel to at-risk locales. Clinicians should ensure that routine nationally recommended vaccines are up to date and protect players by administering immunizations appropriate for specific geographic&#x000a0;locations and the season, including influenza and COVID-19.<xref ref-type="bibr" rid="article-29408.r7">[7]</xref></p>
        <p>
<bold>Review of Systems</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiac: Syncope, presyncope, dizziness, dyspnea or chest pain with exercise, palpitations</p>
          </list-item>
          <list-item>
            <p>Respiratory: Dyspnea not related to asthma or poor conditioning</p>
          </list-item>
          <list-item>
            <p>Neurological: Headaches, difficulty concentrating, sleep problems, or fatigue that might be mistaken for concussion symptoms, and seizures</p>
          </list-item>
          <list-item>
            <p>Musculoskeletal: Joint pain, stiffness, limited range of motion of extremities, hypermobility, chronic back pain</p>
          </list-item>
          <list-item>
            <p>Hematologic: Excessive bleeding, easy bruising, or menorrhagia</p>
          </list-item>
          <list-item>
            <p>Psychiatric: Symptoms of depression or other mood disorders that may result in less-than-optimal performance or conditions that could be exacerbated by the mental and physical stress of competitive sports</p>
          </list-item>
        </list>
        <p>&#x000a0;<bold>Physical Examination</bold></p>
        <p>The complete physical examination begins with assessing vital signs and then targets the cardiovascular, respiratory, musculoskeletal, and neurological systems. Elevated blood pressure and&#x000a0;bradycardia should be noted. Many healthy athletes have a&#x000a0; low resting heart rate, which is usually of no concern but may suggest inadequate caloric intake&#x000a0;associated with an eating disorder. Body weight and body mass index (BMI) may indicate the need for further investigation. A low BMI or body fat percentage may suggest&#x000a0;rapid weight loss in wrestlers ("cutting") or an eating disorder, especially in female athletes.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Eyes: Protective eyewear is recommended if the best-corrected vision is less than 20/40, especially for basketball.</p>
          </list-item>
          <list-item>
            <p>Skin: Evidence of contagious infections such as tinea corporis, scabies, molluscum contagiosum, and impetigo disqualifies athletes in sports with close physical contact or shared equipment like gymnastics mats.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Respiratory: Evidence of wheezing may be associated with poorly controlled asthma.</p>
          </list-item>
          <list-item>
            <p>Cardiovascular: Irregular rhythm, murmurs, S3, or S4 on auscultation must be evaluated. Heaves, lifts, or thrills&#x000a0;may indicate a previously undiagnosed cardiac condition. Absent femoral pulses suggest coarctation of the aorta.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Abdomen: Organomegaly is a disqualification for contact sports participation.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Genitourinary: The presence of a solitary testis requires the use of a protective athletic cup, especially in contact sports. Tanner staging for biological maturity may aid athletes in choosing sports in which they are likely to succeed.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Musculoskeletal: The examination should highlight high-risk areas such as shoulders, knees, and ankles. Arachnodactyly and pectus chest deformities are associated with Marfan Syndrome. Prominent tibial tuberosities are present in Osgood-Schlatter's disease. Patients with Ehlers-Danlos Syndrome may exhibit joint hypermobility.&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Further Evaluation</bold>
</p>
        <p>For healthy athletes without symptoms, no routine laboratory studies are recommended. Evaluation should be individualized, such as obtaining a complete blood count to look for anemia if evidence of malnutrition is present. Electrocardiograms and echocardiograms are not indicated in the absence of clinical concerns. Unnecessary diagnostic&#x000a0;tests may result in false-positive findings and lead to further invasive testing, which is costly and may cause harm and anxiety to the patient.</p>
        <list list-type="bullet">
          <list-item>
            <p>Electrocardiogram (ECG):&#x000a0;The decision to undergo testing should be&#x000a0;discussed between the physician and the patient. It is critical to distinguish between abnormal ECG findings within the general population and expected results in athletes.&#x000a0;Concerning findings in athletes include accessory pathways, short PR intervals, long or short QT intervals, epsilon waves, T-wave inversions, and excessive premature ventricular contractions. Normal ECG findings in athletes include bradycardia, sinus arrhythmia, ventricular enlargement, and first-degree atrioventricular block. Distinguishing benign and pathologic findings can reduce unnecessary diagnostic testing and treatments.<xref ref-type="bibr" rid="article-29408.r8">[8]</xref>&#x000a0;Consulting cardiologists&#x000a0;often perform echocardiography when clinically significant conditions are diagnosed.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Consultations: Besides cardiologists, examining clinicians refer patients to other specialists when indicated. An example is consulting with a nephrologist before a patient with a solitary kidney plays contact sports since that is a possible contraindication to participation. Patients with eating disorders benefit from gynecologic and nutrition consultations.&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Consequences of the Evaluation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Most healthy young athletes are fully cleared for sports participation.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>For athletes who are not cleared, they may be able to safely play with limitations, such as excluding contact sports. Others may be temporarily banned. Players with febrile illnesses must wait until the resolution of any&#x000a0;infectious process for their health and to prevent the disease&#x000a0;from spreading to teammates. The COVID-19 pandemic resulted in new, changing restrictions, and clinicians should check current professional and public health guidelines. Before returning to play, a physician should clear patients with more than mild COVID-19 illness. Patients&#x000a0;with severe symptoms&#x000a0;like multi-system inflammatory syndrome should be restricted from sports for three to six months and&#x000a0;evaluated by a cardiologist before returning to play. Uncontrolled hypertension is a condition that prevents participation, and treatment may need to be modified since some diuretics and beta blockers are prohibited by various sports. Patients with sickle cell trait are at increased risk of sudden death during strenuous exercise and require anticipatory interventions to prevent hyperthermia and dehydration.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>It is unusual for athletes to be permanently excluded from all sports. In those cases, clinicians should provide explanations and empathy and, if possible, guide&#x000a0;patients toward safe activities to receive the benefits of exercise and socialization that sports offer.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29408.s4" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The likelihood&#x000a0;of sudden cardiac&#x000a0;arrest&#x000a0;is minimal in athletes, at&#x000a0;less than&#x000a0;one per&#x000a0;100,000 athlete-years.<xref ref-type="bibr" rid="article-29408.r9">[9]</xref>&#x000a0;Athletes who experience possible cardiac symptoms, especially episodes of unexplained syncope, may be at risk.&#x000a0;However, the differential diagnosis for syncope in athletes includes non-cardiac causes, such as vasovagal events, heatstroke,&#x000a0;dehydration, and blunt trauma. A comprehensive sports participation evaluation can reassure athletes and their families that they are&#x000a0;at low risk of sudden cardiac arrest, death, or&#x000a0;other predictable&#x000a0;injury.&#x000a0;</p>
        <p>
<bold>Cardiac Conditions Associated With&#x000a0;Cardiac Arrest in Athletes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypertrophic Obstructive Cardiomyopathy (the most common cause of sudden death in young athletes)<xref ref-type="bibr" rid="article-29408.r10">[10]</xref><xref ref-type="bibr" rid="article-29408.r11">[11]</xref><xref ref-type="bibr" rid="article-29408.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Coronary Artery Anomaly (the second most common cause of sudden death in young athletes)</p>
          </list-item>
          <list-item>
            <p>Coronary Artery Disease (the most common&#x000a0;overall cause of death in athletes of any age due to its relatively high prevalence among older athletes)<xref ref-type="bibr" rid="article-29408.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Arrhythmias such as ventricular tachycardia are among the most frequent causes of sudden death.<xref ref-type="bibr" rid="article-29408.r14">[14]</xref><xref ref-type="bibr" rid="article-29408.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Anabolic Steroid Induced Cardiac Disease, including left ventricular hypertrophy<xref ref-type="bibr" rid="article-29408.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>Arrhythmogenic Right Ventricular Dysplasia&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Dilated Cardiomyopathy</p>
          </list-item>
          <list-item>
            <p>Left Ventricular Noncompaction</p>
          </list-item>
          <list-item>
            <p>Congenital Long QT Syndrome</p>
          </list-item>
          <list-item>
            <p>Short QT Syndrome</p>
          </list-item>
          <list-item>
            <p>Brugada Syndrome</p>
          </list-item>
          <list-item>
            <p>Wolff Parkinson White Syndrome</p>
          </list-item>
          <list-item>
            <p>Catecholaminergic Polymorphic Ventricular Tachycardia</p>
          </list-item>
          <list-item>
            <p>Early Repolarization Syndrome</p>
          </list-item>
          <list-item>
            <p>Myocarditis</p>
          </list-item>
          <list-item>
            <p>Commotio Cordis associated with sudden chest wall impact, usually in contact sports</p>
          </list-item>
        </list>
        <p>
<bold>Other Conditions Associated With Injury</bold>
</p>
        <p>Beyond assessing the risk of sudden death, general harm to individual athletes should be evaluated&#x000a0;based on their medical history and chosen sport.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Concussion history&#x000a0;and the risk of neurological harm and chronic traumatic&#x000a0;encephalopathy in contact sports</p>
          </list-item>
          <list-item>
            <p>Rheumatologic disease&#x000a0;and the forced stresses induced&#x000a0;upon already damaged soft tissues&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Orthopedic injuries and ensuring optimal recovery of prior&#x000a0;trauma before returning to competitive sports</p>
          </list-item>
          <list-item>
            <p>Hematologic disorders&#x000a0;that may lead to internal organ bleeding or significant blood loss&#x000a0;after blunt trauma or lacerations</p>
          </list-item>
        </list>
        <p>
<bold>PEDs and Associated Health Risks</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Anabolic steroids induce many symptoms and illnesses, which may increase the long-term risk of early mortality.</p>
          </list-item>
          <list-item>
            <p>Peptide hormones may lead to cardiac structural changes that are tied to cardiac arrest and increase the risk of cancers.</p>
          </list-item>
          <list-item>
            <p>Stimulants can lead to long-term cardiovascular damage and increase the risk of both benign and dangerous arrhythmias.<xref ref-type="bibr" rid="article-29408.r16">[16]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29408.s5" sec-type="Other Issues">
        <title>Other Issues</title>
        <p>Frequently,&#x000a0;teenagers report concussion-like symptoms without a history of head trauma. These include fatigue, sleep problems, difficulty concentrating, and headaches. A standardized sports concussion assessment tool like the SCAT-3 before contact sports can help distinguish concussion symptoms after injury from a patient's baseline report and prevent players from being unnecessarily excluded from participation.<xref ref-type="bibr" rid="article-29408.r17">[17]</xref>&#x000a0;</p>
        <p>The American Academy of Pediatrics suggests inquiring about many additional relevant topics during the sports examination. This is more likely to occur when the pre-participation evaluation occurs in an office rather than a station setting. Even then, time constraints may limit a discussion of the following subjects:</p>
        <list list-type="bullet">
          <list-item>
            <p>Stress and pressure the athlete may be experiencing</p>
          </list-item>
          <list-item>
            <p>Symptoms of depression and&#x000a0;administering a standardized screening tool like the Patient Health Questionnaire (PHQ-9)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Whether or not the athlete feels safe at home</p>
          </list-item>
          <list-item>
            <p>Tobacco&#x000a0;or any substance use&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Substances or supplements intended to promote weight gain or loss</p>
          </list-item>
          <list-item>
            <p>Seat belt use and general safety measures</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29408.s6" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Clinicians and healthcare workers should take an interprofessional team-based approach to ensure&#x000a0;safe participation in sports. Primary care clinicians, including&#x000a0;physicians, physician assistants,&#x000a0;and nurse practitioners, can&#x000a0;screen athletes&#x000a0;for significant medical issues. Pharmacists play a role as educators and assist the clinical team with reviewing medications and substances. The unnecessary use of nutritional and health supplements can be avoided if athletes are&#x000a0;informed and have ready access to consulting pharmacists and registered dietitians.</p>
        <p>The interprofessional team approach is well-suited to pre-participation examinations in a setting with multiple stations to evaluate players.&#x000a0;Nurses can assist with history taking, vital signs, recording growth charts and BMI data, performing parts of the physical examination, completing health forms, coordinating referrals to specialists, and answering patient and family questions. An interprofessional team approach will likely result in the best clinical outcomes for athletes.</p>
      </sec>
      <sec id="article-29408.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29408&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29408">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29408/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29408">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29408.s8">
        <title>References</title>
        <ref id="article-29408.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maron</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Washington</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Baggish</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Maron</surname>
                <given-names>MS</given-names>
              </name>
              <collab>American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology</collab>
            </person-group>
            <article-title>Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.</article-title>
            <source>Circulation</source>
            <year>2015</year>
            <month>Dec</month>
            <day>01</day>
            <volume>132</volume>
            <issue>22</issue>
            <fpage>e267</fpage>
            <page-range>e267-72</page-range>
            <pub-id pub-id-type="pmid">26527714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lick</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Abdel-Aty</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Diaz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dulku</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lochub</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mir</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ricketts</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Preparticipation Sports Physicals: A Comparison of Single Provider and Station-Based Models.</article-title>
            <source>Clin J Sport Med</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>530</fpage>
            <page-range>530-532</page-range>
            <pub-id pub-id-type="pmid">28708703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lehman</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Carl</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>The Preparticipation Physical Evaluation.</article-title>
            <source>Pediatr Ann</source>
            <year>2017</year>
            <month>Mar</month>
            <day>01</day>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>e85</fpage>
            <page-range>e85-e92</page-range>
            <pub-id pub-id-type="pmid">28287681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pigolkin</surname>
                <given-names>YI</given-names>
              </name>
              <name>
                <surname>Shilova</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Zakharov</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Sereda</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Zholinskiy</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Kruglova</surname>
                <given-names>IV</given-names>
              </name>
              <name>
                <surname>Shigeev</surname>
                <given-names>SV</given-names>
              </name>
            </person-group>
            <article-title>[The sudden death among the young persons under effect of the different forms of physical loads].</article-title>
            <source>Sud Med Ekspert</source>
            <year>2019</year>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>50</fpage>
            <page-range>50-55</page-range>
            <pub-id pub-id-type="pmid">30724895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ison</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Ware</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Schwantes-An</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Freeze</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Elmore</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Spoonamore</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>The impact of cardiovascular genetic counseling on patient empowerment.</article-title>
            <source>J Genet Couns</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>570</fpage>
            <page-range>570-577</page-range>
            <pub-id pub-id-type="pmid">30680842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horwitz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Dalhoff</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <article-title>Health consequences of androgenic anabolic steroid use.</article-title>
            <source>J Intern Med</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>285</volume>
            <issue>3</issue>
            <fpage>333</fpage>
            <page-range>333-340</page-range>
            <pub-id pub-id-type="pmid">30460728</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boston</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Bryan</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Immunizations in Athletes.</article-title>
            <source>Sports Health</source>
            <year>2018</year>
            <season>Sep/Oct</season>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>427</fpage>
            <page-range>427-433</page-range>
            <pub-id pub-id-type="pmid">30059267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Interpreting the Athlete's ECG: Current State and Future Perspectives.</article-title>
            <source>Curr Treat Options Cardiovasc Med</source>
            <year>2018</year>
            <month>Nov</month>
            <day>19</day>
            <volume>20</volume>
            <issue>12</issue>
            <fpage>104</fpage>
            <pub-id pub-id-type="pmid">30456469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Landry</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Allan</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Connelly</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Dorian</surname>
                <given-names>P</given-names>
              </name>
              <collab>Rescu Investigators</collab>
            </person-group>
            <article-title>Sudden Cardiac Arrest during Participation in Competitive Sports.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Nov</month>
            <day>16</day>
            <volume>377</volume>
            <issue>20</issue>
            <fpage>1943</fpage>
            <page-range>1943-1953</page-range>
            <pub-id pub-id-type="pmid">29141175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Driel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Asselbergs</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>de Boer</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>van Rossum</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>van Tintelen</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>van der Velden</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Michels</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Hypertrophic cardiomyopathy].</article-title>
            <source>Ned Tijdschr Geneeskd</source>
            <year>2019</year>
            <month>Feb</month>
            <day>07</day>
            <volume>163</volume>
            <pub-id pub-id-type="pmid">30730688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maron</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Shirani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Poliac</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Mathenge</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>FO</given-names>
              </name>
            </person-group>
            <article-title>Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles.</article-title>
            <source>JAMA</source>
            <year>1996</year>
            <month>Jul</month>
            <day>17</day>
            <volume>276</volume>
            <issue>3</issue>
            <fpage>199</fpage>
            <page-range>199-204</page-range>
            <pub-id pub-id-type="pmid">8667563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finocchiaro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Papadakis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Robertus</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Dhutia</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Steriotis</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Tome</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mellor</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Merghani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Behr</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sheppard</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>Etiology of Sudden Death in Sports: Insights From a United Kingdom Regional Registry.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2016</year>
            <month>May</month>
            <day>10</day>
            <volume>67</volume>
            <issue>18</issue>
            <fpage>2108</fpage>
            <page-range>2108-2115</page-range>
            <pub-id pub-id-type="pmid">27151341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eckart</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Shry</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Burke</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>McNear</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Appel</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Castillo-Rojas</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Avedissian</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pearse</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Potter</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Tremaine</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gentlesk</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Huffer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reich</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>WG</given-names>
              </name>
              <collab>Department of Defense Cardiovascular Death Registry Group</collab>
            </person-group>
            <article-title>Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2011</year>
            <month>Sep</month>
            <day>13</day>
            <volume>58</volume>
            <issue>12</issue>
            <fpage>1254</fpage>
            <page-range>1254-61</page-range>
            <pub-id pub-id-type="pmid">21903060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Corrado</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Basso</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schiavon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thiene</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Screening for hypertrophic cardiomyopathy in young athletes.</article-title>
            <source>N Engl J Med</source>
            <year>1998</year>
            <month>Aug</month>
            <day>06</day>
            <volume>339</volume>
            <issue>6</issue>
            <fpage>364</fpage>
            <page-range>364-9</page-range>
            <pub-id pub-id-type="pmid">9691102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chistiakov</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Myasoedova</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Melnichenko</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Grechko</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Orekhov</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Role of androgens in cardiovascular pathology.</article-title>
            <source>Vasc Health Risk Manag</source>
            <year>2018</year>
            <volume>14</volume>
            <fpage>283</fpage>
            <page-range>283-290</page-range>
            <pub-id pub-id-type="pmid">30410343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r16">
          <label>16</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Farzam</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <chapter-title>Premature Ventricular Contraction</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">30422584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29408.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caccese</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Kontos</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Port</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Valerio</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Broglio</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>McCrea</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McAllister</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Pasquina</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Buckley</surname>
                <given-names>TA</given-names>
              </name>
              <collab>CARE Consortium Investigators</collab>
            </person-group>
            <article-title>Test-Retest Reliability and Efficacy of Individual Symptoms in Concussion Management.</article-title>
            <source>Clin J Sport Med</source>
            <year>2023</year>
            <month>Jan</month>
            <day>01</day>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>52</fpage>
            <page-range>52-60</page-range>
            <pub-id pub-id-type="pmid">36599360</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
